Furthermore, elevated tumor CD73 expression is associated with worse outcomes in several cancers [1, 11], including PDAC [6, 12] and CRC [13, 14], and CD73 may be among the drivers of tumor metastasis [4, 15]. This evidence concerns the gene NT5E and colorectal carcinoma.